ETR:CCAP CORESTATE Capital (CCAP) Stock Price, News & Analysis €0.30 -0.01 (-1.61%) As of 09/15/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About CORESTATE Capital Stock (ETR:CCAP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CORESTATE Capital alerts:Sign Up Key Stats Today's Range€0.29▼€0.3350-Day Range€0.26▼€0.3152-Week Range€0.26▼€0.76Volume2,994 shsAverage VolumeN/AMarket Capitalization€50.58 millionP/E RatioN/ADividend Yield819.67%Price TargetN/AConsensus RatingN/A Company Overview CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC. Read More Receive CCAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CCAP Stock News Headlines1CCAP | Corestate Capital Holding S.A. Stock Overview (Italy: Milan ...September 4, 2025 | barrons.comCorestate Capital Holding S.A.May 27, 2025 | barrons.comSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings!September 16 at 2:00 AM | Goldco Precious Metals (Ad)EQS-Adhoc: Corestate Capital Holding S.A.: Corestate to sell STAM Europe SASApril 10, 2025 | markets.businessinsider.comCorestate Capital Holding SANovember 9, 2024 | morningstar.comMWells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)October 29, 2024 | markets.businessinsider.comLadenburg Thalmann Initiates Coverage of Crescent Capital BDC (CCAP) with Buy RecommendationOctober 1, 2024 | msn.comCrescent Capital: It Has Become A Better Buy After Q1 2024May 29, 2024 | seekingalpha.comSee More Headlines CCAP Stock Analysis - Frequently Asked Questions How have CCAP shares performed this year? CORESTATE Capital's stock was trading at €0.36 at the start of the year. Since then, CCAP shares have decreased by 15.3% and is now trading at €0.31. What other stocks do shareholders of CORESTATE Capital own? Based on aggregate information from My MarketBeat watchlists, some other companies that CORESTATE Capital investors own include bluebird bio (BLUE), Cisco Systems (CSCO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), Aravive (ARAV), Athersys (ATHX) and Atara Biotherapeutics (ATRA). Industry, Sector and Symbol Stock ExchangeETR SectorReal Estate Industry Real Estate Services Sub-IndustryFinancial Services Current SymbolETR:CCAP CIKN/A Webwww.corestate-capital.ch Phone352 26 6372 20FaxN/AEmployees446Year FoundedN/AProfitability EPS (Trailing Twelve Months)(€21.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.01Net Income-€3.50 billion Net Margins-1,143.36% Pretax MarginN/A Return on Equity-269.30% Return on Assets-7.35% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick Ratio0.17 Sales & Book Value Annual Sales€306.04 million Price / Sales0.17 Cash Flow€0.51 per share Price / Cash Flow0.60 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares165,831,023Free FloatN/AMarket Cap€50.58 million OptionableNot Optionable Beta1.03 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (ETR:CCAP) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CORESTATE Capital Holding S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share CORESTATE Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.